Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Joe Fenn

Showing results (31-40 of 37) with videos related to

Pageof 4
Sort By:
You have reached the last page of results.This site can display upto 37 results.
Ebiomedicine|December 12, 2024
An ultra-early, transient interferon-associated innate immune response associates with protection from SARS-CoV-2 infection despite exposureJoe Fenn, Kieran Madon, Emily Conibear, et al.
The Lancet. Infectious Diseases|November 10, 2021
Community transmission and viral load kinetics of the SARS-CoV-2 delta (B.1.617.2) variant in vaccinated and unvaccinated individuals in the UK: a prospective, longitudinal, cohort studyAnika Singanayagam, Seran Hakki, Jake Dunning, et al.
The European Respiratory Journal|November 26, 2021
Broadening symptom criteria improves early case identification in SARS-CoV-2 contactsHamish Houston, Seran Hakki, Timesh D Pillay, et al.
Mucosal Immunology|November 23, 2023
A pro-inflammatory gut mucosal cytokine response is associated with mild COVID-19 disease and superior induction of serum antibodiesDana Costigan, Joe Fenn, Sandi Yen, et al.
The Lancet. Respiratory Medicine|August 21, 2022
Onset and window of SARS-CoV-2 infectiousness and temporal correlation with symptom onset: a prospective, longitudinal, community cohort studySeran Hakki, Jie Zhou, Jakob Jonnerby, et al.
The Lancet. Microbe|April 9, 2023
Risk factors and vectors for SARS-CoV-2 household transmission: a prospective, longitudinal cohort studyNieves Derqui, Aleksandra Koycheva, Jie Zhou, et al.
Nature Communications|November 30, 2024
SARS-CoV-2 human challenge reveals biomarkers that discriminate early and late phases of respiratory viral infectionsJoshua Rosenheim, Rishi K Gupta, Clare Thakker, et al.
Pageof 4

Showing results (31-40 of 37) with videos related to

Sort By:
Pageof 4
You have reached the last page of results.This site can display upto 37 results.
Ebiomedicine|December 12, 2024
An ultra-early, transient interferon-associated innate immune response associates with protection from SARS-CoV-2 infection despite exposureJoe Fenn, Kieran Madon, Emily Conibear, et al.
The Lancet. Infectious Diseases|November 10, 2021
Community transmission and viral load kinetics of the SARS-CoV-2 delta (B.1.617.2) variant in vaccinated and unvaccinated individuals in the UK: a prospective, longitudinal, cohort studyAnika Singanayagam, Seran Hakki, Jake Dunning, et al.
The European Respiratory Journal|November 26, 2021
Broadening symptom criteria improves early case identification in SARS-CoV-2 contactsHamish Houston, Seran Hakki, Timesh D Pillay, et al.
Mucosal Immunology|November 23, 2023
A pro-inflammatory gut mucosal cytokine response is associated with mild COVID-19 disease and superior induction of serum antibodiesDana Costigan, Joe Fenn, Sandi Yen, et al.
The Lancet. Respiratory Medicine|August 21, 2022
Onset and window of SARS-CoV-2 infectiousness and temporal correlation with symptom onset: a prospective, longitudinal, community cohort studySeran Hakki, Jie Zhou, Jakob Jonnerby, et al.
The Lancet. Microbe|April 9, 2023
Risk factors and vectors for SARS-CoV-2 household transmission: a prospective, longitudinal cohort studyNieves Derqui, Aleksandra Koycheva, Jie Zhou, et al.
Nature Communications|November 30, 2024
SARS-CoV-2 human challenge reveals biomarkers that discriminate early and late phases of respiratory viral infectionsJoshua Rosenheim, Rishi K Gupta, Clare Thakker, et al.
Pageof 4